Increased CD28 serum levels are not associated with specific clinical activity in systemic lupus erythematosus-Reference-Cited by-同舟云学术

Increased CD28 serum levels are not associated with specific clinical activity in systemic lupus erythematosus

Published:2010-04-14 Issue:10 Volume:31 Page:1321-1324
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Brambila-Tapia Aniel J. L.,Gámez-Nava Jorge I.,Salazar-Páramo Mario,Muñoz-Valle José F.,González-López Laura,Llamas-Covarrubias Mara A.,Gutiérrez-Ureña Sergio R.,Vázquez-Del Mercado Mónica,Dávalos-Rodríguez Ingrid P.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-010-1479-1.pdf

Reference9 articles.

1. Kaneko H, Saito K, Hashimoto H, Yagita H, Okumura K, Azuma M (1996) Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin Exp Immunol 106:218–229

2. Alvarado C, Alcocer-Varela J, Llorente L, Richaud-Patin Y, Cerbon M, Alarcon-Segovia D (1994) Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus. J Autoimmun 7:763–773

3. Wong CK, Lit LCW, Tam LS, Li EK, Lam CWK (2005) Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 44:989–994

4. Hebbar M, Jeannin P, Magistrelli G, Hatron PY, Hachulla E, Devulder B, Bonnefoy JY, Delneste Y (2004) Detection of circulating soluble CD28 in patients with lupus erythematosus, primary Sjögren syndrome and systemic sclerosis. Clin Exp Immunol 136:388–392

5. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Derivation of the SLEDAI (1992) A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of the CD28 markers with the disease activity in systemic lupus erythematosus patients;F1000Research;2023-10-18

2. Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects;The Journal of Clinical Pharmacology;2016-08-23

3. Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus;Molecular Biology Reports;2012-10-09